Cross-check FDA warning letters at fda.gov against the pharmacy and its parent company
The way I like to think about it is an evidence ladder, moving from mechanism to molecules to models to humans: At the time of writing, there are no peer-reviewed, controlled human data showing weight-loss or metabolic benefits for this product
Experimental literature has linked IGF-1 activity to keratinocyte migration, wound resolution, collagen organization, and improved healing outcomes across several preclinical models, making CJC-1295 No DAC with Ipamorelin relevant to investigations of how endocrine signaling shapes the molecular environment for tissue maintenance and restoration [9]

Research Focus Areas Investigations into copper transport and biological copper homeostasis Studies of dermal fibroblast collagen and elastin synthesis in cell culture Examination of wound-healing pathways in rodent skin models Antioxidant and superoxide-dismutase mimetic activity in in-vitro assays Hair-follicle and dermal-papilla cell research Quality & Verification Synthesized via solid-phase peptide synthesis (SPPS) in an ISO-certified facility 99% purity verified by reverse-phase HPLC Cu content confirmed by atomic absorption spectroscopy or ICP-MS Independent third-party Certificate of Analysis available on request Sequence: Gly-His-Lys (with Cu coordination) Storage & Handling Store lyophilized vials at 20C for long-term stability (protected from light) Once reconstituted, store at 28C and use within 2830 days Avoid repeated freeze-thaw cycles Sealed under nitrogen and shipped in insulated packaging Preclinical Research Summary GHK-Cu is the copper(II) complex of the endogenous human tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys)

Your doctor will then determine the correct dosage for you
Whitehouse F, Kruger DF, Fineman M, et al